What's new in HER2+ mBC from ASCO 2023
ASCO® 2023 Insights: "A Randomized Controlled Trial Comparing Primary Tumor Resection + Systemic Therapy With Systemic Therapy Alone in mBC (PRIM-BC) - Japan Clinical Oncology Group Study JCOG1017"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Tadahiko Shien
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Tadahiko Shien
Login to view comments.
Click here to Login
What's new in HER2+ mBC from ASCO 2023